FDA opens office in China to regulate safety of exported drugs

BMJ 2008; 337 doi: (Published 25 November 2008) Cite this as: BMJ 2008;337:a2700
  1. Susan Mayor
  1. 1London

    The US regulatory agency the Food and Drug Administration has opened its first branches abroad—in Beijing, Guangzhou, and Shanghai—to improve the safety of products imported from China into the United States.

    The new branches are part of a strategy, called “beyond our borders,” to improve the safeguards applied to food and drugs that are imported into the United States, acknowledging the increasingly global market. Further branches of the FDA are planned in India, Europe, Latin America, and the Middle East.

    Michael Leavitt, secretary of the US Department …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to to receive unlimited access to all content on for 14 days.
    Sign up for a free trial